$16.85
Price
$12.5B
Market Cap
—
P/E Ratio
-16.9
Forward P/E
$-1.25
EPS (TTM)
—
Dividend Yield
$239M
Cash
$7M
Total Debt
744M
Shares Out
$15.55
$36.91
52-Week Range
Institutional Ownership of Summit Therapeutics Inc.
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Summit Therapeutics Inc.
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for Summit Therapeutics Inc.
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.